1Chakrabarti A. Microbiology of systemic fungal infections. J Postgrad Med, 2005, 51 ( Suppl 1 ) : 16-20.
2Brown J. Zygomycosis: an emerging fungal infection. Am J Heath Syst Pharm, 2005, 62(24): 2593-2596.
3Ribes JA, Vanover-Sams CL, Baker DL. Zygomycetes in human disease. Clin Microbiol Rev, 2000, 13(2) :236-301.
4Bemard M, Latge JP. AspergiUus fumigatus cell wall : composition and biosynthesis. Med Mycol, 2001, 39 (Suppl 1 ) :9-17.
5Granville L, Chirala M, Cernoch P, et al. Fungal sinusitis: histologic spectrum and correlation with culture. Hum Pathol, 2004, 35(4): 474-481.
6Larkin JA, Montero JA. Fungal infection efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med, 2003, 20 : 201-206.
7Ritz N, Ammann RA, Aebischer CC, et al. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. EurJ Pediatr, 2005, 164(4): 231- 235.
8Kobayashi K, Kami M, Murashige N, et al. Breakthrough zygomycosis during voriconazole treatment for invasive aspergiUosis, Haematologica, 2004, 89 ( 11 ) : e42.
9Jensen HE, Halbeek B, Lind P, et al. Development of murine monoclonal antibodies for the immunohistochemical diagnosis of systemic bovine aspergillosis. J Vet Diagn Invest, 1996, 8( 1 ) : 68-75.
10Fenelon LE, Hamilton AJ, Figueroa JI, et al. Production of specific monoclonal antibodies to Aspergillus species and their use immunohistochemical identification of aspergillosis. J Clin Microbiology, 1999, 37(4) : 1221-1223.
